Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer

Clinical trial NCT02822157 · UNKNOWN

Trial details

NCT number: NCT02822157
Sponsor: Universitaire Ziekenhuizen KU Leuven
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Epithelial Cancer

Start date: 2016-08-01
Primary completion: 2021-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.